NTLA Award Disclosure
Marantz Jing L. · SEC Form 4 · Filed Oct 28, 2026
Award
Calculated transaction value
$0
Marantz Jing L. EVP, Chief Medical Officer
NTLA
Transaction date
Oct 26, 2026
Public filing date
Oct 28, 2026
Filing lag
Filed 2 days later
NTLA daily price context
Close on/before transaction
$11.26
Oct 26, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 275,061 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-436131
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Intellia Therapeutics, Inc. NTLA Current | Award | Oct 26, 2026 | $0 |
| Intellia Therapeutics, Inc. NTLA | Award | Oct 26, 2026 | $0 |